iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
Go back to iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.28 +0.03 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $0.80 | |||
| Open | $1.26 | 52 Week Low | $0.34 | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $-0.08 | |||
| Volume | 445,359 | |||||
| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.28 +0.03 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $0.80 | |||
| Open | $1.26 | 52 Week Low | $0.34 | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $-0.08 | |||
| Volume | 445,359 | |||||
